Factors Influencing Treatment Adherence Among Drug-Sensitive Tuberculosis (DS-TB) Patients in Armenia: A Qualitative Study

References

• World Health Organization. Tuberculosis [fact sheet]; 2021. Accessed August 13, 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed August 13, 2022.
   Google Scholar
• World Health Organization. Global Tuberculosis Report; 2019.
   Google Scholar
• Volmink J, Garner P. Directly observed therapy for treating tuberculosis [Systematic Review]. Cochrane Database Syst Rev. 2005;4. doi: 10.1002/14651858
   Web of Science ®Google Scholar
• Uplekar M, Figueroa-Munoz J, Floyd K. The stop TB strategy: building on and enhancing DOTS to meet the TB-related millennium development goals. WHO Rep. 2006;22. doi:10.2165/00128413-200615310-00002
   Google Scholar
• World Health Organization. Adherence to Long-Term Therapies. Evidence for Action; 2003.
   Google Scholar
• World Health Organization. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Health Policy Plan. 2008;86. doi:10.1093/heapol/czh031
   Web of Science ®Google Scholar
• Kulkarni P, Akarte S, Mankeshwar R, Bhawalkar J, Banerjee A, Kulkarni A. Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment. Ann Med Health Sci Res. 2013;3(1):67–74. doi:10.4103/2141-9248.109507
   PubMedGoogle Scholar
• Truzyan N, Grigoryan R, Martirosyan H, et al. Operational research on risk factors for MDR TB and MDR TB-HIV/AIDS co-morbidity; 2012.
   Google Scholar
• World Health Organization. Treatment of tuberculosis. guidelines for treatment of drug-susceptible tuberculosis and patient care; 2017.
   Google Scholar
• United Nations. The Millennium Development Goals Report. Vol. 72. United Nations; 2015.
   Google Scholar
• Riccardi N, Alagna R, Motta I, et al. Towards ending TB: civil community engagement in a rural area of Senegal: results, challenges and future proposal. Infect Dis. 2019;51(5):392–394. doi:10.1080/23744235.2019.1572920
   PubMed Web of Science ®Google Scholar
• Vink K, Colombani P, Mosneaga A, et al. Tuberculosis assessment mission to Armenia. World Health Organization; 2005. Available from: https://www.euro.who.int/__data/assets/pdf_file/0019/123166/TubArmAss.pdf. Accessed August 23, 2022.
   Google Scholar
• World Health Organization. Global tuberculosis Control: WHO report 2007; 2007.
   Google Scholar
• Truzyan N, Crape B, Harutyunyan T, Petrosyan V. Family-based tuberculosis counseling supports directly observed therapy in Armenia: a pilot project. J Tuberc Res. 2018;6:113–124. doi:10.4236/jtr.2018.62011
   Google Scholar
• Khachadourian V, Truzyan N, Harutyunyan A, et al. People-centred care versus clinic-based DOT for continuation phase TB treatment in Armenia: a cluster randomized trial. BMC Pulm Med. 2020;20(1):1–10. doi:10.1186/s12890-020-1141-y
   PubMed Web of Science ®Google Scholar
• Sanchez-Padilla E, Marquer C, Kalon S, et al. Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study. Int J Tuberc Lung Dis. 2014;18:160–167. doi:10.5588/ijtld.13.0369
   PubMed Web of Science ®Google Scholar
• Sahakyan S, Petrosyan V, Abrahamyan L. Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study. Int J Public Health. 2020;65(1):37–43. doi:10.1007/s00038-019-01277-2
   PubMed Web of Science ®Google Scholar
• World Health Organization. Tuberculosis Country Brief, 2016: Armenia.; 2017.
   Google Scholar
• World Health Organization. Implementing the WHO Stop TB Strategy: a handbook for national tuberculosis control programmes; 2008. Available from: http://apps.who.int/iris/bitstream/handle/10665/43792/9789241546676_eng.pdf;jsessionid=287C1F41696423D354F8850510E31E3E?sequence=1. Accessed August 23, 2022.
   Google Scholar
• World Health Organization. Tuberculosis: key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed May 21, 2020.
   Google Scholar
• World Health Organization. Revised Definitions and Reporting Framework for Tuberculosis - 2013 Revision. Vol. 18; 2013.
   Google Scholar
• Kreuter M, Green L. Health Program Planning: An Educational and Ecological Approach. 4th ed. McGraw-Hill; 2005.
   Google Scholar
• Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–1288. doi:10.1177/1049732305276687
   PubMed Web of Science ®Google Scholar
• Gebremariam MK, Bjune G, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study. BMC Public Health. 2010;10(1):651. doi:10.1186/1471-2458-10-651
   PubMed Web of Science ®Google Scholar
• Munro S, Lewin S, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238. doi:10.1371/journal.pmed.0040238
   PubMed Web of Science ®Google Scholar
• Shargie EB, Lindtjørn B. Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007;4(2):e37. doi:10.1371/journal.pmed.0040037
   PubMed Web of Science ®Google Scholar
• Martin LR, Haskard KB, Dimatteo MR, Dimatteo MR. The challenge of patient adherence. Therapeutics and Clinical Risk Management. 2005;1(3):189–199.
   PubMedGoogle Scholar
• Tonoyan T, Muradyan L. Health inequalities in Armenia - Analysis of survey results. Int J Equity Health. 2012;11(1):1. doi:10.1186/1475-9276-11-32
   PubMed Web of Science ®Google Scholar
• Andreasyan D, Bazarchyan A, Manukyan S, et al. Health system performance assessment: Armenia; 2016.
   Google Scholar
• Wang J, Fei Y, Shen H, Xu B. Gender difference in knowledge of tuberculosis and associated health-care seeking behaviors: a cross-sectional study in a rural area of China. BMC Public Health. 2008;8:354. doi:10.1186/1471-2458-8-354
   PubMed Web of Science ®Google Scholar
• Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002;6(7):573-579.
   Google Scholar
• Paz-soldán VA, Alban RE, Jones CD, Oberhelman RA. The provision of and need for social support among adult and pediatric patients with tuberculosis in Lima, Peru: a qualitative study. BMC Health Services Research. 2013;13. doi10.1186/1472-6963-13-290
   PubMed Web of Science ®Google Scholar
• Kaulagekar-nagarkar A, Dhake D, Jha P. Perspective of tuberculosis patients on family support and care in rural Maharashtra. Indian J Tuberc. 2012;411007:224–230.
   Google Scholar
• Reach G. Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients. Patient Prefer Adherence. 2011;5:523–531. doi:10.2147/PPA.S24518
   PubMed Web of Science ®Google Scholar
• Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(SUPPL. 4):34–42. doi:10.1177/00333549101250s407
   PubMed Web of Science ®Google Scholar
• De Schacht C, Mutaquiha C, Faria F, et al. Barriers to access and adherence to tuberculosis services, as perceived by patients: a qualitative study in Mozambique. PLoS One. 2019;14(7):1–11. doi:10.1371/journal.pone.0219470
   Web of Science ®Google Scholar
• Gebreweld FH, Kifle MM, Gebremicheal FE, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Heal Popul Nutr. 2018;37(1):1. doi:10.1186/s41043-017-0132-y
   PubMed Web of Science ®Google Scholar
• International Organization for Migration. Migrant health survey on TB and HIV and health service response for migrants; 2018.
   Google Scholar
• Dara M, Krtchyan Z, Ghukasyan G. Extensive review of TB prevention, care and control services in Armenia 21 April – 4 May 2011; 2011.
   Google Scholar
• Grigoryan R, Truzyan N, Martirosyan H, Crape B, Petrosyan V, Antonyan M. Analysis of the TB control system in Armenia in both the civilian and penitentiary sectors and recommendations for improvement. Yerevan; 2008.
   Google Scholar
• Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003;167(11):1472–1477. doi:10.1164/rccm.200206-626OC
   PubMed Web of Science ®Google Scholar
• Sharma SK, Mohan A. Directly Observed Treatment, Short-Course (DOTS). J Indian Acad Clin. 2004;5(2):109–113.
   Google Scholar
• Riccardi N, Villa S, Alagna R, et al. Advantages and challenges of tailored regimens for drug-resistant tuberculosis: a stoptb Italia look into the future. Infect Drug Resist. 2020;13:2795–2800. doi:10.2147/IDR.S257480
   PubMed Web of Science ®Google Scholar